Yale Cancer Center study shows checkpoint inhibitor prolongs survival in pa

Compared to the standard therapy, survival was significantly improved for participants with previously untreated recurrent or metastatic head and neck cancers.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news